Tower Research Capital (TRC)’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
Other funds holding AYTU
AIC
CAM
Tower Research Capital (TRC)'s AYTU Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its AYTU BioPharma (AYTU) stake by 31% in Q3 2026, selling an estimated $1.53K and leaving 1,541 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4936.
Tower Research Capital (TRC) first reported a position in AYTU in Q2 2019 and has held it in 27 quarters since. The position peaked at $54K in Q2 2021. 36 funds tracked by Wall St. Rank hold AYTU as of Q3 2026.
- Tower Research Capital (TRC) held 1,541 shares of AYTU BioPharma worth $3.3K as of Q3 2026.
- Tower Research Capital (TRC) sold 691 AYTU BioPharma shares in Q3 2026, an estimated $1.53K.
- AYTU BioPharma made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4936 holding.
- Tower Research Capital (TRC) first reported a position in AYTU BioPharma in Q2 2019 and has held it in 27 quarters since.
- Tower Research Capital (TRC)'s AYTU BioPharma position peaked at $54K in Q2 2021.
- 36 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.